ID

25556

Descripción

Study part: Study Conclusion. A Single Blind, Parallel Group, Up-titration, Phase 1 Study in Healthy Volunteers to Determine a Starting Dose and Select an Up-titration Regimen for a new Formulation of Ropinirole. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Phase: phase 1. Study Recruitment Status: Completed Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP, Zygara; Zygara, ZIPEREVE, ZEPREVE, Requip Depot, REQUIP, REPREVE, Modutab, ADARTREL. Study Indication : Restless Legs Syndrome. Study ID: 101468/201. Clinical Study ID: 101468/201

Palabras clave

  1. 5/9/17 5/9/17 -
  2. 10/5/19 10/5/19 -
  3. 10/5/19 10/5/19 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

5 de septiembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Study Conclusion Ropinirole Restless Legs Syndrome 101468/201

Study Conclusion

  1. StudyEvent: ODM
    1. Study Conclusion
STUDY CONCLUSION
Descripción

STUDY CONCLUSION

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Subject number
Descripción

Subject number

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348585
Did the subject complete the study as planned?
Descripción

study subject participation status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
If ‘No’, mark one most appropriate category:
Descripción

reason

Tipo de datos

integer

Alias
UMLS CUI [1]
C0392360
Other, please specify
Descripción

Other

Tipo de datos

text

Alias
UMLS CUI [1]
C0205394
Comments on reason for withdrawal:
Descripción

reason for withdrawal

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0008976
Date of withdrawal:
Descripción

Date of withdrawal

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C2349954
Time of withdrawal:
Descripción

Time of withdrawal

Tipo de datos

time

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C2349954
Date of final dose:
Descripción

Date of final dose

Tipo de datos

date

Alias
UMLS CUI [1]
C1531784
Time of final dose:
Descripción

Time of final dose

Tipo de datos

time

Alias
UMLS CUI [1,1]
C1522314
UMLS CUI [1,2]
C0013227

Similar models

Study Conclusion

  1. StudyEvent: ODM
    1. Study Conclusion
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
STUDY CONCLUSION
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
study subject participation status
Item
Did the subject complete the study as planned?
boolean
C2348568 (UMLS CUI [1])
Item
If ‘No’, mark one most appropriate category:
integer
C0392360 (UMLS CUI [1])
Code List
If ‘No’, mark one most appropriate category:
CL Item
Adverse event (complete adverse event form)  (1)
CL Item
Insufficient therapeutic effect  (2)
CL Item
Deviation from protocol (including non-compliance)  (3)
CL Item
Lost to Follow-Up  (4)
CL Item
Other (5)
Other
Item
Other, please specify
text
C0205394 (UMLS CUI [1])
reason for withdrawal
Item
Comments on reason for withdrawal:
text
C2349954 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Date of withdrawal
Item
Date of withdrawal:
date
C0011008 (UMLS CUI [1,1])
C2349954 (UMLS CUI [1,2])
Time of withdrawal
Item
Time of withdrawal:
time
C0040223 (UMLS CUI [1,1])
C2349954 (UMLS CUI [1,2])
Date of final dose
Item
Date of final dose:
date
C1531784 (UMLS CUI [1])
Time of final dose
Item
Time of final dose:
time
C1522314 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial